Log in to search using one of your social media accounts:

 

Controversial epilepsy drug that causes birth defects is banned
The Medicines and Healthcare Products Regulatory Agency has changed the licence for sodium valproate, which controls electrical functions in the brain to prevent life-threatening seizures. (Source: the Mail online | Health)
Source: the Mail online | Health - April 24, 2018 Category: Consumer Health News Source Type: news

Cannabidiol Cuts Seizure Severity, Frequency in Resistant Epilepsy Cannabidiol Cuts Seizure Severity, Frequency in Resistant Epilepsy
One of the main components of cannabis, cannabidiol, decreased seizure frequency by 50% to 60% in children and adults with treatment-refractory epilepsy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 24, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

UK safety regulator beefs up rules relating to epilepsy drug
The UK licence and guidance relating to sodium valproate have been changed in the wake of the recent announcement of new Europe-wide safety measures relating to the drug. (Source: Nursing Times)
Source: Nursing Times - April 24, 2018 Category: Nursing Source Type: news

New ban on epilepsy drug in pregnancy
Valproate will no longer be given to girls and women of childbearing age unless they sign a consent form. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 24, 2018 Category: Consumer Health News Source Type: news

UK bans Sanofi epilepsy drug without pregnancy prevention plan
LONDON (Reuters) - A Sanofi drug for epilepsy and bipolar disorder linked to thousands of birth defects has been banned in Britain for use in women or girls of child-bearing age, unless they are on a special pregnancy prevention program. (Source: Reuters: Health)
Source: Reuters: Health - April 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Too Few Adults Taking Epilepsy Meds Have Seizure Control
MONDAY, April 23, 2018 -- Although most adults with epilepsy report taking epilepsy medication, less than half of those report having their seizures controlled, according to research published in the April 20 issue of the U.S. Centers for Disease... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 23, 2018 Category: Pharmaceuticals Source Type: news

UCB to Expand Epilepsy Portfolio With Strategic Acquisition of Midazolam Nasal Spray From Proximagen
Midazolam Nasal Spray (USL261), is a nasally administered investigational midazolam formulation intended as a rescue treatment of acute repetitive seizures (ARS) in patients with epilepsy, which has completed Phase 3 clinical development and is ready to be... Biopharmaceuticals, Neurology, Acquisitions UCB , Proximagen, Midazolam, epilepsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2018 Category: Pharmaceuticals Source Type: news

FDA Backs Cannabis Drug for Severe Epilepsy
FDA Panel Unanimously Backs Cannabis Drug for Severe Epilepsy (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 20, 2018 Category: General Medicine Source Type: news

Debate goes on over valproate in pregnancy
Should there be an outright ban or restricted use of valproate in women who could get pregnant? Related items fromOnMedica Antidepressants in pregnancy linked to heightened risk of birth defects Epilepsy drug linked to 4,000 birth defects in France Prenatal exposure to valproate raises risk of autism Hunt announces Medicines and Medical Devices Safety Review Include pregnant women in studies, urge researchers (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 20, 2018 Category: UK Health Source Type: news

Cannabis effect on cognitive function small and short-lived
Associations are small and may be of questionable clinical importance for most individuals, study suggests Related items fromOnMedica Cannabis use increases hospital admissions for psychotic patients Cannabis-related hospital admissions reach 10-year high in Scotland Teen cannabis use linked to substance misuse in adulthood Cannabis derivative interferes with antiepileptic drugs Cannabis compound may help curb frequency of epileptic seizures (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 20, 2018 Category: UK Health Source Type: news

Experts back marijuana-based drug for childhood seizures
Medicine made from the cannabis plant for severe seizures in children with epilepsy ​ has moved one step closer to U.S. approval (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - April 19, 2018 Category: Consumer Health News Source Type: news

FDA Panel Unanimously Backs Cannabis Drug for Severe Epilepsy FDA Panel Unanimously Backs Cannabis Drug for Severe Epilepsy
An FDA advisory committee has voted to support approval of a formulation of cannabidiol as an adjunctive treatment for Lennox-Gastaut syndrome and Dravet syndrome in patients 2 years of age or older.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 19, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

F.D.A. Panel Recommends Approval of Cannabis-Based Drug for Epilepsy
Epidiolex was developed to treat two rare and devastating forms of the disease. It contains a chemical compound found in marijuana but not the one that makes people high. (Source: NYT Health)
Source: NYT Health - April 19, 2018 Category: Consumer Health News Authors: SHEILA KAPLAN Tags: Marijuana Food and Drug Administration Epilepsy Seizures (Medical) Drugs (Pharmaceuticals) Epidiolex GW Pharmaceuticals Source Type: news

FDA Panel Backs Epidiolex for Rare, Severe Epilepsy
(MedPage Today) -- Cannabidiol medication would be first cannabis-derived drug approved in U.S. (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 19, 2018 Category: American Health Source Type: news

FDA panel approves marijuana-based epilepsy drug
A FDA advisory committee unanimously approved an experimental drug made from marijuana to treat seizures associated rare epilepsy affecting children. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 19, 2018 Category: Consumer Health News Source Type: news

FDA Panel Votes To Approve Marijuana-Based Drug For Epilepsy
The drug, Epidiolex, was developed by London's GW Pharmaceuticals and is a pharmaceutical-grade form of cannabidiol, or CBD, an oil found in marijuana plants. GW grows the plant in greenhouses and purifies out the CBD. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 19, 2018 Category: Pharmaceuticals Authors: Michela Tindera, Forbes Staff Tags: NASDAQ:GWPH Source Type: news

GW Pharma gets FDA panel nod, first cannabis-based drug nearing approval
(Reuters) - An advisory panel to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of approving the first cannabis-derived medicine in the country, a childhood epilepsy treatment developed by GW Pharma. (Source: Reuters: Health)
Source: Reuters: Health - April 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Marijuana-derived drug for epilepsy gets FDA committee recommendation
A US Food and Drug Administration advisory committee on Thursday unanimously recommended approval of an epilepsy drug that would be the first plant-derived cannabidiol medicine for prescription use in the United States. (Source: CNN.com - Health)
Source: CNN.com - Health - April 19, 2018 Category: Consumer Health News Source Type: news

Marijuana-derived drug for epilepsy gets FDA recommendation
A US Food and Drug Administration advisory committee on Thursday unanimously recommended approval of an epilepsy drug that would be the first plant-derived cannabidiol medicine for prescription use in the United States. (Source: CNN.com - Health)
Source: CNN.com - Health - April 19, 2018 Category: Consumer Health News Source Type: news

Active Epilepsy and Seizure Control in Adults — United States, 2013 and 2015
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - April 19, 2018 Category: American Health Source Type: news

FDA panel unanimously backs GW Pharma's cannabis-based epilepsy drug
(Reuters) - GW Pharmaceuticals Plc's cannabis-derived drug to treat a severe form of childhood epilepsy was unanimously backed on Thursday by an advisory panel to the U.S. Food and Drug Administration. (Source: Reuters: Health)
Source: Reuters: Health - April 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

US experts back marijuana-based drug for childhood seizures
US panel says a medicine made from the marijuana plant should be approved to treat severe epileptic seizures in children (Source: ABC News: Health)
Source: ABC News: Health - April 19, 2018 Category: Consumer Health News Tags: Health Source Type: news

FDA panel unanimously votes for GW Pharma's cannabis-derived epilepsy drug
(Reuters) - GW Pharmaceuticals Plc's cannabis-based drug to treat a severe form of childhood epilepsy was unanimously backed on Thursday by an advisory panel to the U.S. Food and Drug Administration. (Source: Reuters: Health)
Source: Reuters: Health - April 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Panel: FDA Should OK Marijuana-Based Epilepsy Drug
The committee recommended that Epidiolex, an oral solution, be approved for treatment of severe, early-onset forms of epilepsy in a small number of patients. (Source: WebMD Health)
Source: WebMD Health - April 19, 2018 Category: Consumer Health News Source Type: news

Unanimous Positive Result of FDA Advisory Committee Meeting for First Plant-Based Pharmaceutical Cannabidiol Treatment for Seizures in Patients with Two Rare, Severe Forms of Epilepsy
LONDON and CARLSBAD, Calif., April 19, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) ( “GW”, “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 19, 2018 Category: Drugs & Pharmacology Source Type: news

UPV/EHU researchers account for the complex symptoms of Angelman syndrome
(University of the Basque Country) A research group at the Faculty of Science and Technology of the UPV/EHU-University of the Basque Country has managed to reliably identify the changes in the proteins altered by the UBE3A enzyme, responsible for Angelman syndrome. This disease causes problems in intellectual and motor development, epilepsy, difficulties in communication, and very few hours of sleep. Funding provided by the Angelman Syndrome Association has been a key factor in being able to complete the research. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 19, 2018 Category: Biology Source Type: news

UCalgary researchers develop a new method to discover drugs to treat epilepsy
(University of Calgary) For more than a third of children living with epilepsy, the currently approved medications do not stop their seizures. Researchers at the Cumming School of Medicine have developed a new drug screening method to discover drugs to treat epilepsy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2018 Category: International Medicine & Public Health Source Type: news

Epilepsy drug that causes birth defects should NOT be banned during pregnancy, scientists argue
According to consultant neurologists, from the Royal Free London NHS Foundation Trust, the controversial medication sodium valproate may be the only effective treatment in certain patients. (Source: the Mail online | Health)
Source: the Mail online | Health - April 18, 2018 Category: Consumer Health News Source Type: news

Mass. General Trial Uses Marijuana-Based Medicine To Reduce Seizures
BOSTON (CBS) – It could be the first-ever drug made from part of a marijuana plant approved by the federal government and one family here in Massachusetts says it’s already making a huge difference in their lives. Emma Newcomer tightly holds on to a few pieces of laminated paper, covered in square photos. These photos are how she talks to the world. By pointing at the different pictures, she communicates if she’s hungry or wants to play. The 13-year-old has a severe form of epilepsy. She can suffer up to 100 seizures a day. Emma Newcomer, 13, right, who has epilepsy, is benefiting from taking a marij...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 18, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall Source Type: news

Alfie Dingley's family apply for licence for medical cannabis
Alfie Dingley's family want him use cannabis oil to treat his epilepsy, which is illegal in the UK. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 18, 2018 Category: Consumer Health News Source Type: news

FDA staff backs epilepsy drug made from cannabis plant
Staff at the FDA have approved an experimental drug made from a marijuana plant used to treat children with two rare forms of epilepsy. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 17, 2018 Category: Consumer Health News Source Type: news

LivaNova wins CE Mark for SenTiva VNS epilepsy treatment
LivaNova (NSDQ:LIVN) said today it won CE Mark in the European Union for its Vagus Nerve Stimulation Therapy system, now indicated for treating patients with drug-resistant epilepsy. The VNS Therapy system is composed of the London-based company’s SenTiva implantable generator and a next-gen VNS therapy programming system. LivaNova touted the SenTiva generator as the smallest and lightest responsive therapy for epilepsy on the market. The system features a wireless wand and tablet-based interface to allow for physician-directed therapy for patients with drug-resistant epilepsy. “CE Mark combined with recen...
Source: Mass Device - April 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Neurological Neuromodulation/Neurostimulation Regulatory/Compliance LivaNova Source Type: news

Marijuana-Based Medicine To Reduce Seizures Gets Positive FDA Review
WASHINGTON (AP) — A closely watched medicine made from the marijuana plant reduces seizures in children with severe forms of epilepsy and warrants approval in the United States, health officials said Tuesday. British drugmaker GW Pharmaceuticals is seeking permission to sell its purified form of an ingredient found in cannabis — one that doesn’t get users high — as a medication for rare, hard-to-treat seizures in children. If successful, the company’s liquid formula would be the first government-approved drug derived from the cannabis plant in the U.S. The Food and Drug Administration’s ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 17, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Cannabidiol Epidiolex Local TV Marijuana Oil Source Type: news

GW cannabis-derived epilepsy drug gets positive FDA staff review
LONDON (Reuters) - GW Pharmaceuticals' cannabis-derived medicine for severe childhood epilepsy won a favorable review from U.S. Food and Drug Administration (FDA) staff on Tuesday, boosting hopes for its approval in the world's biggest drugs market. (Source: Reuters: Health)
Source: Reuters: Health - April 17, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Marijuana-based drug gets positive review from US agency
Federal health officials say a closely watched medicine made from the marijuana plant significantly reduces seizures in children with severe forms of epilepsy and warrants approval in the U.S. (Source: ABC News: Health)
Source: ABC News: Health - April 17, 2018 Category: Consumer Health News Tags: Health Source Type: news

Zimbabwe:Govts Must Educate People About Epilepsy
[The Herald] In October 2017 Abdul Matola was stoned and burnt to death in Malawi after being accused of being a "bloodsucking vampire". Matola had lived with uncontrolled epilepsy -- a highly treatable and non-infectious condition characterised by recurring seizures. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 17, 2018 Category: African Health Source Type: news

Epilepsy Linked to Increased Death From Accidents, Suicide Epilepsy Linked to Increased Death From Accidents, Suicide
A new study focusing on unnatural deaths in people with epilepsy suggests that psychiatric disease and psychiatric medication make a significant contribution to these deaths.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 16, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Africa:People With Epilepsy Aren't Protected in Africa
[The Conversation Africa] In October 2017 Abdul Matola was stoned and burnt to death in Malawi after being accused of being a "bloodsucking vampire". Matola had lived with uncontrolled epilepsy -- a highly treatable and non-infectious condition characterised by recurring seizures. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 15, 2018 Category: African Health Source Type: news

Neurostimulation device offers new hope for those with epilepsy
According to the Epilepsy Foundation about 48 of every 100,000 people will develop epilepsy, a condition that can cause debilitating seizures. But there's new hope thanks to advancements in science and technology. Dr. Jon LaPook reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - April 14, 2018 Category: Consumer Health News Source Type: news

Medical News Today: Epilepsy raises risk of unnatural death, study finds
Researchers have associated a diagnosis of epilepsy with a greater risk of suicide, accidental drug poisoning, and other unnatural causes of death. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 12, 2018 Category: Consumer Health News Tags: Epilepsy Source Type: news

Dementia: This common drug increases dementia risk by up to 60 percent
A DRUG that is widely used to treat epilepsy and bipolar disorder in the UK has been found to increase the risk of dementia by up to 60 percent by breaking down brain cells. (Source: Daily Express - Health)
Source: Daily Express - Health - April 10, 2018 Category: Consumer Health News Source Type: news

Epileptics are up to 5 times more likely to die by suicide
Epilepsy strikes 600,000 people in the UK and closer to three million in the US, according to figures. Researchers at Manchester and Swansea universities led the new trial into the condition. (Source: the Mail online | Health)
Source: the Mail online | Health - April 10, 2018 Category: Consumer Health News Source Type: news

Medtronic wins CE Mark for Visualase brain surgery device
Medtronic (NYSE:MDT) said today that it won CE Mark approval in the European Union for its Visualase brain surgery device. Fridley, Minn.-based Medtronic said the MRI-guided Visualase system uses a small-diameter probe to deliver laser energy to ablate soft tissue in the brain. It’s been approved in the U.S. since 2007, the company said. “The introduction of Visualase to European physicians ensures that more patients will have access to this beneficial technology,” brain therapies president Brett Wall said in prepared remarks. “This latest milestone is a testament to our commitment to expanding...
Source: Mass Device - April 10, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Neurological Regulatory/Compliance Medtronic Source Type: news

Patients with epilepsy at ‘increased risk of unnatural death’
Patients diagnosed with epilepsy in England and Wales are at increased risk of dying from suicide and accidents, according to researchers. (Source: Nursing Times)
Source: Nursing Times - April 10, 2018 Category: Nursing Source Type: news

The clinical characteristics of posttraumatic epilepsy following moderate-to-severe traumatic brain injury in children - Keret A, Shweiki M, Bennett-Back O, Abed-Fteiha F, Matoth I, Shoshan Y, Benifla M.
We examined the long-term incidence and risk factors for developing PTE in a cohort of children hospita... (Source: SafetyLit)
Source: SafetyLit - April 10, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Epileptogenesis, traumatic brain injury, and biomarkers - Engel J.
Epilepsy is one of the most common brain disorders, causing serious disability and premature death worldwide. Approximately 1.2% of the U.S. population has active epilepsy, and 30 to 40% have seizures that do not respond to antiseizure drugs. There current... (Source: SafetyLit)
Source: SafetyLit - April 10, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Epilepsy Diagnosis Tied to Suicide, Accident Risk (CME/CE)
(MedPage Today) -- Risk of medication poisoning, intentional or not, is particularly high (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - April 9, 2018 Category: Neurology Source Type: news

2 lots of the epilepsy drug Primidone recalled over lead levels
AA Pharma Inc. is voluntarily recalling two lots of Primidone tablets, Health Canada says. (Source: CBC | Health)
Source: CBC | Health - April 9, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

Epileptics are up to 5 TIMES more likely to commit suicide
Epilepsy strikes 600,000 people in the UK and closer to three million in the US, according to figures. Researchers at Manchester and Swansea universities led the new trial into the condition. (Source: the Mail online | Health)
Source: the Mail online | Health - April 9, 2018 Category: Consumer Health News Source Type: news